Trinity Biotech TRIB Q4 2024 Earnings Deep EPS Miss Weighs on Investor Sentiment CSR Q1 2026 Earnings EPS Misses Estimates Sharply Stock Gains on Strategic Outlook BTE Q1 2026 Earnings Severe EPS Miss Highlights Operational Challenges NLY Q1 2026 Earnings Slight EPS Beat Amid Uncertain Rate Environment and Modest Stock Decline BNR Q3 2022 Earnings EPS Surpasses Estimates Amid Operational Challenges GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development